Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol Tablets Due to Possibility of Inexact Tablet Counts or Out of Sequence Tablets

On January 31, 2012, the F.D.A. posted a press release from Pfizer, Inc. announcing the recent recall of two brands of the drug company’s oral contraceptives due to incorrect packaging and erroneous sequencing of tablets. The two recalled brands, Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol, are oral contraceptives prescribed for the prevention of pregnancy. Pfizer identified an inexact count of active and inactive tablets and a problem with the sequential order of tablets in 14 lots of each respective recalled brand.

According to Pfizer, Inc., the packaging error may lead to an incorrect administration of the daily regimen of these contraceptives. This error could in turn lead to unintended pregnancy in women taking either of these brands of oral contraceptives. The company advises that patients who take either of these drugs use a non-hormonal type of contraception right away. Pfizer also recommends that patients taking either drug notify their doctors and return the recalled product to their pharmacy.

See the full F.D.A. press release at: